Patents Assigned to GLAXOSMITHKLINE BIOLOGICALS, NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GMBH & CO KG.
  • Patent number: 10398771
    Abstract: A process for producing a split influenza virus preparation or subunit influenza preparation comprising the steps of: (i) providing a whole virus preparation; (ii) splitting the whole virus preparation in the presence of a first detergent; (iii) adding t-octylphenoxypolyethoxyethanol (TRITON X-100™) to the resulting split virus preparation; and (iv) filtering the split virus preparation.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: September 3, 2019
    Assignees: GLAXOSMITHKLINE BIOLOGICAL S.A., GLAXOSMITHKLINE BIOLOGICALS, NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GMBH & CO KG
    Inventors: Erik Jozef D'Hondt, Hans Bernd Engelmann
  • Publication number: 20170196968
    Abstract: A process for producing a split influenza virus preparation or subunit influenza preparation comprising the steps of: (i) providing a whole virus preparation; (ii) splitting the whole virus preparation in the presence of a first detergent; (iii) adding t-octylphenoxypolyethoxyethanol (TRITON X-100™) to the resulting split virus preparation; and (iv) filtering the split virus preparation.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 13, 2017
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, GLAXOSMITHKLINE BIOLOGICALS, NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GMBH & CO KG.
    Inventors: Erik Jozef D'HONDT, Hans Bernd ENGELMANN
  • Patent number: 9636394
    Abstract: A process for producing a split influenza virus preparation or subunit influenza preparation comprising the steps of: (i) providing a whole virus preparation; (ii) splitting the whole virus preparation in the presence of a first detergent; (iii) adding t-octylphenoxypolyethoxyethanol (TRITON X-100™) to the resulting split virus preparation; and (iv) filtering the split virus preparation.
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: May 2, 2017
    Assignees: GLAXOSMITHKLINE BIOLOGICALS SA, GLAXOSMITHKLINE BIOLOGICALS, NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GMBH & CO KG.
    Inventors: Erik Jozef D'Hondt, Hans Bernd Engelmann